A Potential New Therapeutic Option For The Treatment Of Nonmuscle Invasive Bladder Cancer: Combination Of Intravesical Oncotherad Immunotherapy And Platelet Rich Plasma (Prp).

JOURNAL OF CLINICAL ONCOLOGY(2021)

引用 1|浏览5
暂无评分
摘要
461Background: Effective intravesical therapies remain lacking for non-muscle invasive bladder cancer (NMIBC) when Bacillus Calmette-Guerin fails. OncoTherad is a nanostructured inorganic phosphate...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要